Introduction
Vascular disease is a major cause of mortality and morbidity worldwide. Current investigations have shown an association between vascular pathology and decreased bioavailability of nitric oxide (NO). The NO generated by endothelial nitric oxide synthase (eNOS) in the vascular endothelium is a vasoprotectant that regulates vasoreactivity, activation of platelets, expression of adhesion molecules, infiltration of monocytes into the intima, apoptosis of endothelial cells, and proliferation of smooth muscle cells. This regulation ultimately leads to reduced plaque formation and improved maintenance of vascular tone and integrity. Impaired endothelial function causes abnormalities in the arterial wall and is an early and critical event in atherosclerosis (Li and Forstermann, 2009 ).
The eNOS produces NO by hydrolyzing L-arginine. However, L-arginine can also be converted to L-ornithine and urea by arginase, and increasing arginase activity may induce endothelial dysfunction by decreasing eNOS activity via substrate depletion (Berkowitz et al., 2003) . Arginase I and II are distinct enzymes encoded by different genes (Haraguchi et al., 1987; Morris et al., 1997) . Arginase I catalyzes the final step of the urea cycle in the liver, although its expression is also induced by hypoxia and lipopolysaccharide (LPS) in a variety of cells and tissues (Chang et al., 1998) . Arginase II is the extrahepatic isoform and controls cell proliferation and differentiation in endothelial cells by providing ornithine for polyamine synthesis (Ignarro et al., 2001; Li et al., 2001) . Expression of arginase II is induced by factors such as LPS, TNFα, and hypoxia in a variety of tissues (Collado et al., 2006; Louis et al., 1998; Modolell et al., 1995; Morris et al., 1998) . Furthermore, the role of arginase II in endothelial dysfunction has recently been observed in animal models of aging (Berkowitz et al., 2003) , ischemia-reperfusion injury (Hein et al., 2003; Jung et al., 2010) , hypertension Lucigenin-enhanced chemiluminescence (5 μ M, lucigenin) was recorded using a luminometer (Monolight TM 3010) (Ryoo et al., 2008) .
Measurement of NO and reactive oxygen species (ROS)
All experimental procedures using mice were approved by the Institutional Review Board at Kangwon National University. Aortic rings from 10-week-old male C57BL/6 WT mice were prepared for biochemical assays of arginase activity or fluorescent probe labeling of superoxide (dihydroethidine [DHE] , 1 μ mol/L, 5 min) or NO (4-amino-5-methylamino-2´,7´-
μ mol/L, 5 min). Images were acquired using Olympus BX51 epifluorescence microscope. Fluorescence intensity was measured as previously described (Ryoo et al., 2008) using Metamorph software.
Western blot and eNOS dimer blot analyses
Cells were lysed in SDS sample buffer (62.5 mM Tris, pH 6.8, 2% SDS, and 10% glycerol) and sonicated for 5 seconds to reduce sample viscosity. Each sample was resolved by 10% SDS-PAGE, transferred to PVDF membranes (Bio-Rad, Hercules, CA), analyzed with antibodies according to the supplier's protocol, and visualized with peroxidase and enhanced chemiluminescence (Thermo Scientific, Rockford, IL). Samples were normalized to β -tubulin (1:1000, BD Bioscience, Franklin Lakes, NJ). Densitometry analysis of bands was performed using NIH ImageJ. Dimers and monomers of eNOS were separated by lowtemperature SDS-PAGE and analyzed as described above (Ryoo et al., 2008) .
Vascular tension assay
Male C57BL/6J wild type (WT) and HCD-fed ApoE -/-mice (D12108C, Research Diet Inc., USA) were anesthetized using isoflurane and the thoracic aortic vessel was rapidly removed.
The aorta was placed in ice-cold oxygenated Krebs-Ringer bicarbonate solution (in mM;
This article has not been copyedited and formatted. The final version may differ from this version. DMT-620) containing 10 ml Krebs-Ringer (95% O 2 -5% CO 2 , pH 7.4, 37˚C). One stirrup was connected to a three-dimensional micromanipulator and the other to a force transducer. The rings were passively stretched at 10-minute intervals in increments of 100 mg to reach optimal tone (600 mg). After the arterial rings had been stretched to their optimal resting tone, the contractile response to 100 mM KCl was determined. The response to a maximal dose of 
TDF-induced arginase inhibition reciprocally increased NO production and decreased

ROS generation
In HUVECs, TDF incubation increased NO production in a dose-dependent manner intensity/second in the untreated group to 1.56±0.07 intensity/second in the TDF-treated group, whereas the NOS inhibitor L-NAME reduced the slope to 0.17±0.04 intensity/second (Fig. 3B ). Time-dependent fluorescence intensity of DHE was lower in TDF-treated aortas, with a DHE fluorescence slope of 0.25±0.04 intensity/second (versus 0.33±0.04
intensity/second in the untreated control), and was nearly quenched with MnTBAP (0.035±0.001 intensity/second) (Fig. 3C ). Lucigenin chemiluminescence showed that xanthine reacted with xanthine oxidase to produce superoxide, indicating TDF was not acting as a ROS scavenger and did not affect the chemiluminescence signal ( Fig. 3D ).
TDF induced eNOS phosphorylation and dimerization but did not change protein content in HUVECs
As shown in Fig. 4A , TDF had no effect on the content of proteins, eNOS, or arginase I or II, and did not increase expression of inducible NOS (iNOS). However, TDF incubation significantly increased phosphorylation of eNOS at Ser1177 from 0.85 to 1.00 arbitrary units (AU) and resulted in a 36% increase in the dimer form of eNOS ( Fig. 4B ). We further tested that direct effect of TDF itself on eNOS dimerization by incubating cell lysates with TDF.
However, TDF had no effect on eNOS dimerization (data not shown).
TDF enhanced NO signaling in aortic vessels isolated from WT mice
Because TDF augmented NO production in the aortic endothelium through enhanced eNOS phosphorylation and dimerization, we tested the effect of TDF on vessel reactivity in aortic vessels from WT mice. To confirm the effect of TDF on endothelium-dependent vasorelaxation, vessels were preconstricted with phenylephrine (PE, 5×10 -5 M), and doseresponse curves of the endothelium-dependent vasodilator acetylcholine (Ach) and the This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
Arginase expressed in the vascular endothelium reciprocally regulates eNOS activity, which is associated with development of vascular diseases. Therefore, arginase inhibition may have a beneficial effect on vascular diseases associated with endothelial dysfunction by restoring eNOS activity. Here we demonstrated that TDF from Scutellaria indica was a dosedependent, non-competitive inhibitor of arginase activity and increased NO production through eNOS coupling and phosphorylation at Ser1177. These TDF-mediated effects contributed to Ach-dependent vasorelaxation in WT and atherosclerosis-prone ApoE -/-mice fed a HCD. The inhibitory activity of TDF was comparable to that of ABH, a boronic acid derivative known to inhibit arginase.
NO has multiple vasoprotective characteristics, which has led researchers to investigate NO- inhibition restores endothelial dysfunction (Steppan et al., 2013) . Therefore, TDF may be a good model for further development of an effective and safe novel therapeutic compound for atherosclerosis. The present study showed that TDF was a potent arginase inhibitor and improved endothelial dysfunction by attenuating the vasoconstriction response to PE and U46619, and augmenting the vasorelaxation response to Ach through by increasing NO bioavailability in normal (Fig. 5) and HCD-fed atherogenic-prone mice (Fig. 7) .
Arginase activity reciprocally regulated eNOS-dependent NO production (Fig. 3) The HCD increased serum LDL and activity of arginase II, which is the major arginase isoform in mouse aortic vessels (Ryoo et al., 2008) , in ApoE -/-mice (Fig. 6A ).
The protein content of eNOS increases in animal models of atherosclerosis (Kawashima, 2004) . Relative to WT mice, eNOS-overexpressing mice have increases in HCD-induced atherosclerotic lesions whereas eNOS-deficient mice have decreases in lesions (Ozaki et al., 2002; Shi et al., 2002) . As shown in Fig. 6 , NO production decreased in HCD-fed ApoE -/-mice despite an increased abundance of eNOS protein, suggesting that coupling of eNOS activity and NO production is more important than increasing eNOS protein content.
Furthermore, eNOS inhibition with L-NAME significantly decreased ROS production in HCDfed ApoE -/-mice, suggesting that uncoupled eNOS is an important ROS-producing enzyme that contributes to atherosclerosis ( . We showed that arginase inhibition with TDF induced eNOS phosphorylation at Ser1177 and increased the ratio of eNOS dimer/monomer (Fig. 3 and 6, respectively) . A previous study showed arginase inhibition did not change BH4 content, total biopterin, or BH4/BH2 ratio (Ryoo et al., 2008) . Therefore, arginase inhibition may have an alternative mechanism for eNOS coupling associated with phosphorylation that accompanies the increase in L-arginine concentration. Indeed, increased arginase activity with a high-fat diet (HFD) has been associated with p38 MAPK activation and subsequent eNOS uncoupling, whereas arginase II-null mice fed a HFD have reduced activation of p38 MAPK in the aorta, which protects them from eNOS uncoupling and endothelial dysfunction (Yu et al., 2014 ).
In conclusion, we showed that TDF non-competitively inhibited arginase activity and reciprocally increased NO production through increased eNOS phosphorylation and dimerization. TDF improved vascular function in both ND-fed WT and HCD-fed ApoE -/-mice.
These results suggest that TDF may contribute to the improvement of vascular diseases caused by endothelial dysfunction. and xanthine oxidase-derived superoxide production. All statistical analyses were performed by t-test. 
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